These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29371969)

  • 1. MiR-124 acts as a target for Alzheimer's disease by regulating BACE1.
    An F; Gong G; Wang Y; Bian M; Yu L; Wei C
    Oncotarget; 2017 Dec; 8(69):114065-114071. PubMed ID: 29371969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-186 is decreased in aged brain and suppresses BACE1 expression.
    Kim J; Yoon H; Chung DE; Brown JL; Belmonte KC; Kim J
    J Neurochem; 2016 May; 137(3):436-45. PubMed ID: 26710318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-15b represses BACE1 expression in sporadic Alzheimer's disease.
    Gong G; An F; Wang Y; Bian M; Yu LJ; Wei C
    Oncotarget; 2017 Oct; 8(53):91551-91557. PubMed ID: 29207665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-16 attenuates β-amyloid-induced neurotoxicity through targeting β-site amyloid precursor protein-cleaving enzyme 1 in an Alzheimer's disease cell model.
    Zhong Z; Yuan K; Tong X; Hu J; Song Z; Zhang G; Fang X; Zhang W
    Neuroreport; 2018 Nov; 29(16):1365-1372. PubMed ID: 30142113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-16-5p and miR-19b-3p prevent amyloid β-induced injury by targeting BACE1 in SH-SY5Y cells.
    Zhang N; Li WW; Lv CM; Gao YW; Liu XL; Zhao L
    Neuroreport; 2020 Feb; 31(3):205-212. PubMed ID: 31876684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-149 is downregulated in Alzheimer's disease and inhibits β-amyloid accumulation and ameliorates neuronal viability through targeting BACE1.
    Du W; Lei C; Dong Y
    Genet Mol Biol; 2021; 44(1):e20200064. PubMed ID: 33428703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-132-3p alleviates neuron apoptosis and impairments of learning and memory abilities in Alzheimer's disease by downregulation of HNRNPU stabilized BACE1.
    Qu J; Xiong X; Hujie G; Ren J; Yan L; Ma L
    Cell Cycle; 2021 Nov; 20(21):2309-2320. PubMed ID: 34585626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-98-5p Acts as a Target for Alzheimer's Disease by Regulating Aβ Production Through Modulating SNX6 Expression.
    Li Q; Li X; Wang L; Zhang Y; Chen L
    J Mol Neurosci; 2016 Dec; 60(4):413-420. PubMed ID: 27541017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-34a-5p and miR-125b-5p attenuate Aβ-induced neurotoxicity through targeting BACE1.
    Li P; Xu Y; Wang B; Huang J; Li Q
    J Neurol Sci; 2020 Jun; 413():116793. PubMed ID: 32251872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-200a-3p Mediates Neuroprotection in Alzheimer-Related Deficits and Attenuates Amyloid-Beta Overproduction and Tau Hyperphosphorylation
    Wang L; Liu J; Wang Q; Jiang H; Zeng L; Li Z; Liu R
    Front Pharmacol; 2019; 10():806. PubMed ID: 31379578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-4422-5p as a Negative Regulator of Amyloidogenic Secretases: A Potential Biomarker for Alzheimer's Disease.
    Hajjari SN; Sadigh-Eteghad S; Shanehbandi D; Teimourian S; Shahbazi A; Mehdizadeh M
    Neuroscience; 2021 May; 463():108-115. PubMed ID: 33836245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-β induced neurotoxicity and neuroinflammation by sponging miR-374b-5p.
    Zhang J; Wang R
    Exp Gerontol; 2021 Feb; 144():111180. PubMed ID: 33279663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA BACE1-AS Promotes Autophagy-Mediated Neuronal Damage Through The miR-214-3p/ATG5 Signalling Axis In Alzheimer's Disease.
    Zhou Y; Ge Y; Liu Q; Li YX; Chao X; Guan JJ; Diwu YC; Zhang Q
    Neuroscience; 2021 Feb; 455():52-64. PubMed ID: 33197504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease.
    Fang M; Wang J; Zhang X; Geng Y; Hu Z; Rudd JA; Ling S; Chen W; Han S
    Toxicol Lett; 2012 Feb; 209(1):94-105. PubMed ID: 22178568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin ameliorate memory deficits and inflammation in clinical and mouse model of Alzheimer's disease via modulating the expression of miR-106b.
    Huang W; Li Z; Zhao L; Zhao W
    Biomed Pharmacother; 2017 Aug; 92():46-57. PubMed ID: 28528185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
    Liu CG; Wang JL; Li L; Wang PC
    Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The beta-secretase, BACE: a prime drug target for Alzheimer's disease.
    Vassar R
    J Mol Neurosci; 2001 Oct; 17(2):157-70. PubMed ID: 11816789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galangin-induced down-regulation of BACE1 by epigenetic mechanisms in SH-SY5Y cells.
    Zeng H; Huang P; Wang X; Wu J; Wu M; Huang J
    Neuroscience; 2015 May; 294():172-81. PubMed ID: 25779965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice.
    Devi L; Ohno M
    Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.